Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on February 9, 2009

Circulation. 2009
Published online before print February 9, 2009, doi: 10.1161/CIRCULATIONAHA.108.791723
A more recent version of this article appeared on February 24, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
119/7/940    most recent
CIRCULATIONAHA.108.791723v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kao, W. H. L.
Right arrow Articles by Chakravarti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kao, W. H. L.
Right arrow Articles by Chakravarti, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*SNP
*UniGene
Medline Plus Health Information
*Cardiac Arrest
Related Collections
Right arrow Genomics
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

Submitted on May 16, 2008
Accepted on December 1, 2008

Genetic Variations in Nitric Oxide Synthase 1 Adaptor Protein Are Associated With Sudden Cardiac Death in US White Community-Based Populations

W. H. Linda Kao PhD, MHS, Dan E. Arking PhD, Wendy Post MD, MS, Thomas D. Rea MD, MPH, Nona Sotoodehnia MD, MPH, Ronald J. Prineas MD, PhD, Bryan Bishe BS, Betty Q. Doan PhD, MPH, Eric Boerwinkle PhD, Bruce M. Psaty MD, PhD, Gordon F. Tomaselli MD, Josef Coresh MD, PhD, MHS, David S. Siscovick MD, Eduardo Marbán MD, PhD, Peter M. Spooner PhD, Gregory L. Burke MD, MSc, and Aravinda Chakravarti PhD*

From the Department of Epidemiology (W.H.L.K., W.P., J.C.), McKusick-Nathans Institute of Genetic Medicine (D.E.A., B.B., B.Q.D., A.C.), Department of Medicine (W.H.L.K., D.E.A., W.P., G.F.T., J.C., P.M.S., A.C.), School of Medicine and Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md; Departments of Medicine (T.D.R., N.S., B.M.P., D.S.S.) and Epidemiology (B.M.P., D.S.S.), University of Washington, Seattle; Department of Public Health Sciences (R.J.P., G.L.B.), Wake Forest University School of Medicine, Winston-Salem, NC; Human Genetics Center (E.B.), University of Texas School of Public Health, Houston, Tex; and Cedars-Sinai Heart Institute (E.M.), Cedars-Sinai Medical Center, Los Angeles, Calif.

* To whom correspondence should be addressed. E-mail: aravinda{at}jhmi.edu.

Background—The ECG QT interval is associated with risk of sudden cardiac death (SCD). A previous genome-wide association study demonstrated that allelic variants (rs10494366 and rs4657139) in the nitric oxide synthase 1 adaptor protein (NOS1AP), which encodes a carboxy-terminal PDZ ligand of neuronal nitric oxide synthase, are associated with the QT interval in white adults. The present analysis was conducted to validate the association between NOS1AP variants and the QT interval and to examine the association with SCD in a combined population of 19 295 black and white adults from the Atherosclerosis Risk In Communities Study and the Cardiovascular Health Study.

Methods and Results—We examined 19 tagging single-nucleotide polymorphisms in the genomic blocks containing rs10494366 and rs4657139 in NOS1AP. SCD was defined as a sudden pulseless condition of cardiac origin in a previously stable individual. General linear models and Cox proportional hazards regression models were used. Multiple single-nucleotide polymorphisms in NOS1AP, including rs10494366, rs4657139, and rs16847548, were significantly associated with adjusted QT interval in whites (P<0.0001). In whites, after adjustment for age, sex, and study, the relative hazard of SCD associated with each C allele at rs16847548 was 1.31 (95% confidence interval 1.10 to 1.56, P=0.002), assuming an additive model. In addition, a downstream neighboring single-nucleotide polymorphism, rs12567209, which was not correlated with rs16847548 or QT interval, was also independently associated with SCD in whites (relative hazard 0.57, 95% confidence interval 0.39 to 0.83, P=0.003). Adjustment for QT interval and coronary heart disease risk factors attenuated but did not eliminate the association between rs16847548 and SCD, and such adjustment had no effect on the association between rs12567209 and SCD. No significant associations between tagging single-nucleotide polymorphisms in NOS1AP and either QT interval or SCD were observed in blacks.

Conclusions—In a combined analysis of 2 population-based prospective cohort studies, sequence variations in NOS1AP were associated with baseline QT interval and the risk of SCD in white US adults.


Key words: death, sudden • arrhythmia • genetics • epidemiology


Related Article:

Clinical Summaries
Circulation 2009 119: 909-911. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
L. Crotti, M. C. Monti, R. Insolia, A. Peljto, A. Goosen, P. A. Brink, D. A. Greenberg, P. J. Schwartz, and A. L. George Jr
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome
Circulation, October 27, 2009; 120(17): 1657 - 1663.
[Abstract] [Full Text] [PDF]